Editorial Board, Primary Health Care Journal, United Kingdom
Perspective
Role of Endocan in Cardiovascular disorders
Author(s): Georgina Henderson*
Endocan, which was found two decades ago, continues to be a fascinating indicator of inflammation. Endothelial cells release the soluble dermatan sulphate proteoglycan known as endocan. Particularly in hepatocytes, tissues connected to the accelerated proliferation, it is seen to express itself kidneys, lungs, etc. Numerous cardiometabolic conditions that are closely linked to inflammation, such as type 2 diabetes, hypertension, atherosclerotic cardiovascular disease, kidney disease, obesity, polycystic ovary syndrome, metabolic syndrome, non-alcoholic fatty liver disease, etc., have been studied in relation to endocan... View More»
DOI:
10.35248/2332 2594.22.13(5).503
